[heading title_size=”title-size-small” text_align=”center” text_color_custom=”#ffffff” icon_type=”noicon” icon_size=”32″ icon_color=”#de5034″ icon_style=”circle” icon_color_bg=”#ffffff” icon_color_border=”#dbdbdb” icon_border_size=”1″ icon_border_radius=”500″ icon_border_spacing=”50″ subtitle=”Part I”]Groundbreaking, three-part coverage of AdMeTech’s research program in prostate MRI and its potential impact on screening, diagnosis and treatment by the Wall Street Journal.[/heading]
You’ve been getting annual blood tests to check for prostate cancer. But two big studies in the New England Journal of Medicine just found that screening for PSA — prostate specific antigen — doesn’t save many lives. Should you keep checking it?
Your biopsy was negative for prostate cancer but your PSA keeps rising. Should you stop worrying — or have another biopsy?
Read More
